-
Sector Analysis
NewAutomotive Sensors Market Trends, Sector Overview and Forecast to 2028
Automotive Sensors Market Report Overview The automotive sensors market size was 9.49 billion units in 2023. The market will grow at a CAGR of less than 1% during 2023-2028. The growing integration of ADAS features in commercial vehicles is driving an increased demand for sensors. In 2023, Asia-Pacific accounted for a significant share of the market. Automotive Sensors Market Outlook, 2023-2028 (Billion Units) Buy the Full Report for More Insights into the Automotive Sensors Market Download a Free Sample Report...
-
Sector Analysis
NewAutomotive Braking Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Braking Systems Market Report Overview The automotive braking systems market size was 578.5 million units in 2023. The market will grow at a CAGR of more than during 2023-2028. Rapid growth in EV adoption is driving the demand for regenerative braking systems. In 2023, Asia-Pacific accounted for a significant share of the automotive braking systems market. Automotive Braking Systems Market Outlook, 2023-2028 (Million Units) Buy the Full Report for More Insights on the Automotive Braking Systems Market Report Forecast...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cemdisiran in Myasthenia Gravis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cemdisiran in Myasthenia Gravis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cemdisiran in Myasthenia Gravis Drug Details: Cemdisiran is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cemdisiran in Paroxysmal Nocturnal Hemoglobinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cemdisiran in Paroxysmal Nocturnal Hemoglobinuria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cemdisiran in Paroxysmal Nocturnal Hemoglobinuria Drug Details: Cemdisiran is under development...
-
Product Insights
Sumeg Solar PV Park
Sumeg Solar PV Park is a solar PV project located in Veszprem, Hungary. The project is owned and being developed by ESC Eromu Kft. The project is expected to come online in 2026. Empower your strategies with our Sumeg Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
Harrison County Combined Cycle Power Plant
Harrison County Combined Cycle Power Plant is a thermal project located in West Virginia, United States. The project is owned and being developed by ESC Harrison County Power, LLC. The project is at the permitting stage. Empower your strategies with our Harrison County Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Zilebesiran Sodium in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zilebesiran Sodium in Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zilebesiran Sodium in Hypertension Drug Details: Zilebesiran sodium (ALNAGT-01) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIR-2218 in Hepatitis D
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIR-2218 in Hepatitis D report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fitusiran in Hemophilia B (Factor IX Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fitusiran in Hemophilia B (Factor IX Deficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fitusiran in Hemophilia B (Factor IX Deficiency) Drug...